Back

Syndapin-2 mediates amyloid-β transcytosis at the brain endothelium: implications in Alzheimer's disease

Leite, D. M.; Seifi, M.; Swinny, J. D.; Battaglia, G.

2020-07-13 neuroscience
10.1101/2020.07.12.199869 bioRxiv
Show abstract

A deficient transport of amyloid-(A{beta}) across the blood-brain barrier (BBB), and its diminished clearance from the brain, contributes to neurodegenerative and vascular pathologies, including Alzheimers (AD) and cerebral angiopathy, respectively. At the BBB, A{beta} efflux transport is associated with the low-density receptor-related protein 1 (LRP1). However, the precise mechanisms governing A{beta} transport across the BBB, in health and disease, remain to be fully understood. Recent evidence indicates that the LRP1 transcytosis occurs through a tubulation-mediated mechanism stabilised by syndapin-2. Here, we show that syndapin-2 is associated with A{beta} clearance via LRP1 across the BBB. We further demonstrate that risk factors for AD, A{beta} expression and ageing, are associated with a decline in the native expression of syndapin-2 within brain endothelium. Our data reveal that the syndapin-2-mediated pathway, and its balance with the endosomal sorting, are important for A{beta} clearance proposing a measure to evaluate AD and ageing, as well as a target for counteracting A{beta} build-up. Moreover, we provide evidence for the impact of the avidity of A{beta} assemblies in their trafficking across the brain endothelium and in LRP1 expression levels, which may affect the overall clearance of A{beta} across the BBB.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.